购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-49(Compound 81)是一种针对羟基类固醇17β-脱氢酶13(HSD17B13)的抑制剂,其雌二醇IC50值为≤ 0.1 μM。该化合物主要用于研究与肝病、代谢性疾病或心血管疾病相关的疾病,例如非酒精性脂肪肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)或药物引起的肝损伤(DILI)。
HSD17B13-IN-49(Compound 81)是一种针对羟基类固醇17β-脱氢酶13(HSD17B13)的抑制剂,其雌二醇IC50值为≤ 0.1 μM。该化合物主要用于研究与肝病、代谢性疾病或心血管疾病相关的疾病,例如非酒精性脂肪肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)或药物引起的肝损伤(DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-49 (Compound 81) acts as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC50 value of ≤ 0.1 μM for estradiol. It is utilized in studies exploring liver, metabolic, and cardiovascular diseases, including NAFLD, NASH, and drug-induced liver injury (DILI) [1]. |
分子量 | 558.72 |
分子式 | C23H13Cl3F3N3O4 |
CAS No. | 2770246-74-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.